{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:04:23Z","timestamp":1787022263448,"version":"build-2736575974"},"reference-count":17,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of the American Dental Association"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.14219\/jada.archive.2007.0294","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T19:36:21Z","timestamp":1389209781000},"page":"971-977","source":"Crossref","is-referenced-by-count":94,"title":["The treatment of bisphosphonate-associated osteonecrosis of the jaws with bone resection and autologous platelet-derived growth factors"],"prefix":"10.1016","volume":"138","author":[{"given":"Michael C.","family":"Adornato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iyad","family":"Morcos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Rozanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.14219\/jada.archive.2007.0294_bib1","first-page":"6","article-title":"Increasing reports of osteonecrosis associated with use of bisphosphonates","volume":"16","author":"Homes","year":"2005","journal-title":"The Monitor"},{"issue":"9","key":"10.14219\/jada.archive.2007.0294_bib2","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J Oral Maxillofac Surg"},{"issue":"5","key":"10.14219\/jada.archive.2007.0294_bib3","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.joms.2004.02.004","article-title":"Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases","volume":"62","author":"Ruggiero","year":"2004","journal-title":"J Oral Maxillofac Surg"},{"issue":"4","key":"10.14219\/jada.archive.2007.0294_bib4","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1345\/aph.1E357","article-title":"Discovery, clinical development, and therapeutic uses of bisphosphonates","volume":"39","author":"Licata","year":"2005","journal-title":"Ann Pharmacother"},{"issue":"3","key":"10.14219\/jada.archive.2007.0294_bib5","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1210\/jc.2005-0057","article-title":"Long-term safety of bisphosphonates","volume":"90","author":"Ott","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.14219\/jada.archive.2007.0294_bib6","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1600-0714.2004.00269.x","article-title":"Avascular jaw osteonecrosis in association with cancer chemotherapy: series of 10 cases","volume":"34","author":"Bagan","year":"2005","journal-title":"J Oral Pathol Med"},{"issue":"12","key":"10.14219\/jada.archive.2007.0294_bib7","first-page":"1658","article-title":"Managing the care of patients with bisphosphonate-associated osteonecrosis: an American Academy of Oral Medicine position paper (published correction appears in JADA 2006;137[1]:26)","volume":"136","author":"Migliorati","year":"2005","journal-title":"JADA"},{"issue":"4","key":"10.14219\/jada.archive.2007.0294_bib8","first-page":"268","article-title":"Bisphosphonates and avascular necrosis of the jaws","volume":"48","author":"Carter","year":"2003","journal-title":"Aust Dent J"},{"issue":"3","key":"10.14219\/jada.archive.2007.0294_bib9","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.joms.2003.11.003","article-title":"Bisphosphonates and bone necrosis","volume":"62","author":"Pogrel","year":"2004","journal-title":"J Oral Maxillofac Surg"},{"issue":"22","key":"10.14219\/jada.archive.2007.0294_bib10","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1200\/JCO.2003.99.132","article-title":"Bisphosphonates and oral cavity avascular bone necrosis","volume":"21","author":"Migliorati","year":"2003","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.14219\/jada.archive.2007.0294_bib11","first-page":"1675","article-title":"Osteonecrosis of the jaws in patients with a history of receiving bisphosphonate therapy: strategies for prevention and early recognition","volume":"136","author":"Melo","year":"2005","journal-title":"JADA"},{"issue":"6","key":"10.14219\/jada.archive.2007.0294_bib12","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/S1079-2104(98)90029-4","article-title":"Platelet-rich plasma: growth factor enhancement for bone grafts","volume":"85","author":"Marx","year":"1998","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"6","key":"10.14219\/jada.archive.2007.0294_bib13","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1054\/ijom.2002.0322","article-title":"Autologous concentrated platelet-rich plasma (cPRP) for local application in bone regeneration","volume":"31","author":"Dugrillon","year":"2002","journal-title":"Int J Oral Maxillofac Surg"},{"issue":"4","key":"10.14219\/jada.archive.2007.0294_bib14","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.joms.2003.12.003","article-title":"Platelet-rich plasma: evidence to support its use","volume":"62","author":"Marx","year":"2004","journal-title":"J Oral Maxillofac Surg"},{"issue":"4","key":"10.14219\/jada.archive.2007.0294_bib15","first-page":"783","article-title":"Procoagulants and osteonecrosis","volume":"30","author":"Jones","year":"2003","journal-title":"J Rheumatol"},{"issue":"supplement 1","key":"10.14219\/jada.archive.2007.0294_bib16","first-page":"S101","article-title":"Effect of growth hormone and pamidronate on bone blood flow, bone mineral and IGF-I levels in the rat","volume":"49","author":"Kapitola","year":"2000","journal-title":"Physiol Res"},{"issue":"22","key":"10.14219\/jada.archive.2007.0294_bib17","first-page":"6538","article-title":"Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats","volume":"62","author":"Fournier","year":"2002","journal-title":"Cancer Res"}],"container-title":["The Journal of the American Dental Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002817714624247?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002817714624247?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,7]],"date-time":"2018-10-07T09:20:51Z","timestamp":1538904051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002817714624247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":17,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["S0002817714624247"],"URL":"https:\/\/doi.org\/10.14219\/jada.archive.2007.0294","relation":{},"ISSN":["0002-8177"],"issn-type":[{"value":"0002-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2007,7]]}}}